mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.5 |
2e-17 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
2e-15 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
3e-15 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
5e-14 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
6e-09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-08 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-07 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
9e-07 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
9e-07 |